A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for paediatric Crohn's disease
| Autor: | Navas-López, Víctor Manuel, Pujol-Muncunill, Gemma, Llerena, Enrique, Navalón Rubio, María, Gil-Ortega, David, Varea-Calderón, Vicente, Sierra Salinas, Carlos, Martin-de-Carpi, Javier |
|---|---|
| Zdroj: | In Anales de Pediatría (English Edition) February 2018 88(2):89-99 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|